AC
CLB icon

AKO Capital’s Core Laboratories CLB Stock Holding History

AKO Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,365,005
Closed -$53.2M – 27
2021
Q2 		$53.2M Buy
1,365,005
+347,797
+34% +$12.5M 0.6% 26
2021
Q1 		$29.3M Sell
1,017,208
-548,878
-35% -$18.8M 0.36% 27
2020
Q4 		$41.5M Buy
1,566,086
+95,333
+6% +$1.95M 0.54% 26
2020
Q3 		$22.4M Buy
1,470,753
+141,453
+11% +$2.97M 0.35% 25
2020
Q2 		$27M Buy
+1,329,300
New +$23.8M 0.47% 24
2017
Q3 		– Sell
-310,226
Closed -$31.4M – 19
2017
Q2 		$31.4M Buy
310,226
+8,664
+3% +$934K 2.79% 15
2017
Q1 		$34.8M Buy
301,562
+41,619
+16% +$4.84M 3.13% 15
2016
Q4 		$31.2M Buy
+259,943
New +$28.8M 4.01% 11

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

AKO Capital's CLB Position: Q3 2021 in Review

AKO Capital sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 1,365,005 shares — an estimated $53.2M sold.

AKO Capital first reported a position in CLB in Q4 2016 and held it in 8 quarters. The position peaked at $53.2M in Q2 2021. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

  • AKO Capital reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
  • AKO Capital sold 1,365,005 Core Laboratories shares in Q3 2021, an estimated $53.2M.
  • AKO Capital first reported a position in Core Laboratories in Q4 2016 and held it in 8 quarters.
  • AKO Capital's Core Laboratories position peaked at $53.2M in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on AKO Capital's 13F filing for Q3 2021, filed 3 Nov 2021.